Skip to main content
Premium Trial:

Request an Annual Quote

Labcyte, U of Helsinki Extend Personalized Medicine Collaboration

NEW YORK (GenomeWeb) – Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland (FIMM) said today they have expanded their existing personalized medicine partnership to include multiple new applications based on Labcyte's liquid handling and automation platforms.

Specifically, Labcyte and FIMM will now cooperate on cell-based assay development and screening, developing advanced cell models, and integrating Labcyte's Echo liquid handler into FIMM's genomics program as part of the institute's single-cell genomics and population genetics workflows.

FIMM Research Director Janna Saarela said in a statement that the institute has "greatly benefitted" from using Labcyte's acoustic liquid handling technology, and called the collaboration "essential for the successful drug sensitivity testing assays" that FIMM has set up. "Now we aim to expand the use of Labcyte's equipment to our genomic workflows, enabling us to miniaturize assays, make complex liquid handling processes simple, and explore the use of acoustic liquid handling for biobanked DNA samples," Saarela added.

San Jose, California-based Labcyte and FIMM first partnered in 2013, and extended that initial agreement in 2015. The focus of their collaboration has been on developing new strategies for cancer treatment based on functional cell screening.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.